ADX-038 Dose Level 2 clinical trials

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

This study is testing a new medicine, ADX-038, for adults with certain kidney diseases caused by a problem with the body's immune system, called the complement system. We want to see if it's safe and helps people with conditions like IgA nephropathy (IgAN) or C3 glomerulopathy (C3G).